info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0136629-01
Couldn't load pickup availability
LFM-A13 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 μM, 10 μM and 61 μM. LFM-A13 has antiproliferative activity and anticancer activity. LFM-A13 can be used in cancer-related research[1][3][4]
[62004-35-7]
C11H8Br2N2O2
360
C/C(O)=C(C#N)/C(NC1=CC(Br)=CC=C1Br)=O
Btk; JAK; Polo-like Kinase (PLK)
PLK1; PLK3
99.65
10 mM in DMSO
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H302+H312+H332, H315, H319
Loading...
Total items
Product subtotal
LFM-A13 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.